AIP
PRCT icon

Ameritas Investment Partners’s Procept Biorobotics PRCT Stock Holding History

Ameritas Investment Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
5,099
+710
+16% +$17.8K ﹤0.01% 1744
2026
Q1 		$110K Hold
4,389
– – ﹤0.01% 1643
2025
Q4 		$138K Hold
4,389
– – ﹤0.01% 1502
2025
Q3 		$157K Sell
4,389
-975
-18% -$44.5K ﹤0.01% 1384
2025
Q2 		$309K Buy
5,364
+703
+15% +$39.7K 0.01% 1042
2025
Q1 		$272K Hold
4,661
– – 0.01% 1096
2024
Q4 		$375K Buy
4,661
+483
+12% +$41.3K 0.01% 965
2024
Q3 		$335K Hold
4,178
– – 0.01% 1021
2024
Q2 		$255K Hold
4,178
– – 0.01% 1107
2024
Q1 		$206K Hold
4,178
– – 0.01% 1259
2023
Q4 		$175K Buy
4,178
+592
+17% +$20.2K 0.01% 1355
2023
Q3 		$118K Buy
3,586
+605
+20% +$20.6K ﹤0.01% 1536
2023
Q2 		$105K Buy
2,981
+1,061
+55% +$35.1K ﹤0.01% 1564
2023
Q1 		$54.5K Hold
1,920
– – ﹤0.01% 1928
2022
Q4 		$76.3K Hold
1,920
– – ﹤0.01% 1778
2022
Q3 		$79K Hold
1,920
– – ﹤0.01% 1668
2022
Q2 		$62K Buy
1,920
+1,361
+243% +$49.5K ﹤0.01% 1850
2022
Q1 		$20K Hold
559
– – ﹤0.01% 2562
2021
Q4 		$14K Buy
+559
New +$20.7K ﹤0.01% 2796

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameritas Investment Partners's PRCT Position: Q2 2026 in Review

Ameritas Investment Partners increased its Procept Biorobotics (PRCT) stake by 16% in Q2 2026, buying an estimated $17.8K and bringing the position to 5,099 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Ameritas Investment Partners first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $375K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Ameritas Investment Partners held 5,099 shares of Procept Biorobotics worth $115K as of Q2 2026.
  • Ameritas Investment Partners bought 710 Procept Biorobotics shares in Q2 2026, an estimated $17.8K.
  • Procept Biorobotics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1744 holding.
  • Ameritas Investment Partners first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • Ameritas Investment Partners's Procept Biorobotics position peaked at $375K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.